28 related articles for article (PubMed ID: 10223249)
21. Serum CA125 elevation and risk of clinical detection of cancer in asymptomatic postmenopausal women.
Jeyarajah AR; Ind TE; Skates S; Oram DH; Jacobs IJ
Cancer; 1999 May; 85(9):2068-72. PubMed ID: 10223249
[TBL] [Abstract][Full Text] [Related]
22. Screening postmenopausal women for ovarian cancer: a systematic review.
Fung MF; Bryson P; Johnston M; Chambers A;
J Obstet Gynaecol Can; 2004 Aug; 26(8):717-28. PubMed ID: 15307976
[TBL] [Abstract][Full Text] [Related]
23. New tumor markers: CA125 and beyond.
Bast RC; Badgwell D; Lu Z; Marquez R; Rosen D; Liu J; Baggerly KA; Atkinson EN; Skates S; Zhang Z; Lokshin A; Menon U; Jacobs I; Lu K
Int J Gynecol Cancer; 2005; 15 Suppl 3():274-81. PubMed ID: 16343244
[TBL] [Abstract][Full Text] [Related]
24. Screening and early diagnosis of gynecologic cancers.
Warner EA; Parsons AK
Med Clin North Am; 1996 Jan; 80(1):45-61. PubMed ID: 8569300
[TBL] [Abstract][Full Text] [Related]
25. Current approaches and challenges in managing and monitoring treatment response in ovarian cancer.
Marcus CS; Maxwell GL; Darcy KM; Hamilton CA; McGuire WP
J Cancer; 2014 Jan; 5(1):25-30. PubMed ID: 24396495
[TBL] [Abstract][Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
